Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty
Open Access
- 10 September 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (16) , 1952-1960
- https://doi.org/10.1001/archinte.161.16.1952
Abstract
EPIDEMIOLOGIC DATA demonstrate that perioperative and postoperative venous thrombosis are common in high-risk surgical patients.1-5 In the absence of thromboprophylaxis, this disorder occurs in 40% to 60% of patients undergoing hip arthroplasty.5,6 Prophylactic regimens include warfarin and subcutaneous low-molecular-weight heparin.5,6This publication has 21 references indexed in Scilit:
- Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) StudyThrombosis Research, 1998
- A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip ReplacementNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigsBlood Coagulation & Fibrinolysis, 1995
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Prevention of Venous Thromboembolism in General Surgical PatientsAnnals of Surgery, 1988
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleedingJAMA, 1983